Adult Viral Hepatitis Update. Roxanne Ereth, MPH, BS Hepatitis C Program Manager Adult Viral Hepatitis Prevention Coordinator. There are common determinants that lead to transmission of HIV, VH and STD. Unprotected sex Injection drug use (and non-injection!!)
Roxanne Ereth, MPH, BS
Hepatitis C Program Manager
Adult Viral Hepatitis Prevention Coordinator
Injection drug use (and non-injection!!)
Interactions between health concerns increase potential for negative health outcomes.
Untreated STD increase risk of HIV infection.
HIV infection increases the infectiousness of STD (and VH!).
Common strategies can help prevent HIV, VH and STD infection.
Clean needles / syringes Health Education
(Vaccination!!!)Why are collaboration and integration across HIV, VH and STD prevention important?*
*original slide from 2008 National STD Prevention Conference by NASTAD (blue inserts are my comments)
Signs and symptoms typically last <2 months
Relapses possible for 6 months (15%)
Virus shed for 1 – 3 weeks
Most likely 1 -2 weeks before onset
Minimal 1 week afterHepatitis A Impact
The average duration of work loss estimated at 15.5 days for nonhospitalized patients and 33.2 days for hospitalized patients.
Estimates of the annual direct and indirect costs of hepatitis A in the United States have ranged from $300 million to $488.8 million in 1997 dollars.Hepatitis A Impact
Men who have sex with men
Users of injection and non-injection illegal drugs
Persons with clotting factor disorders
Persons working with nonhuman primates susceptible to hepatitis A virusHepatitis A InfectionPersons at Increased Risk
In 2006, an estimated 46,000 persons were newly infected.
Rates are highest among adults, particularly males aged 25–44 years.
4,000-5,000 deaths annually
$658 million in medical costs and lost wages each year
Up to 10% with HIV infected with HBV
Hepatitis B virus is 100 times more infectious than HIVHepatitis B Impact
Men who have sex with men
Sex contacts of infected persons
Injection-drug usersPersons at Increased Risk of Hepatitis B Infection
Infants born to infected mothers
Health-care and public safety workers with exposure to blood
Hemodialysis patientsPersons at Increased Risk of Hepatitis B Infection
Sexually transmitted disease treatment facilities
HIV testing and treatment facilities
Facilities providing drug-abuse treatment and prevention services
Health-care settings targeting services to injection-drug users
Health-care settings targeting services to men who have sex with men
Chronic hemodialysis facilities and end-stage renal disease programs
Institutions and nonresidential day care facilities for developmentally disabled personsHepatitis B Vaccine Recommendations